TL;DR
Get the latest gadgets delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Diraq says it has installed an eight-qubit silicon spin quantum computer at Equinix’s Sydney data center, where the system is now operating. The company calls it the first commercial data center deployment of this technology and says it aims to expand the system to as many as 256 qubits within a year; that target and the system’s future commercial usefulness have not yet been demonstrated.
Diraq says it has installed an eight-qubit silicon spin quantum computer at an Equinix commercial data center in Sydney, Australia, placing the company’s system in an operating facility built for business computing. Diraq describes the installation as the first commercial data center deployment of a silicon spin quantum computer; the announcement marks a move into data center infrastructure, not a demonstration that the machine is already delivering commercial quantum applications.
The system is reported to be operating at Equinix’s Sydney site, where it occupies about 170 square feet and draws less than 20 kilowatts, according to Diraq. The company says its silicon spin processors use semiconductor manufacturing processes also used for conventional chips, and are intended to fit within existing data center environments. Equinix operates facilities used by businesses in sectors including healthcare, finance, utilities and manufacturing.
Diraq is targeting an upgrade to as many as 256 qubits within a year. That is a company target, not a completed upgrade or independently verified performance result. Diraq also estimates that a future utility-scale system could use around 300 kilowatts and occupy as little as 50 square feet. Those figures describe expectations for future systems, rather than the current Sydney installation.
The deployment was announced alongside Diraq’s Quantum at Work report, which discusses prospective uses of quantum computing in areas including medicine, energy, materials, climate and transport. The company’s analysis says a 10-percentage-point improvement in clinical trial success rates could save about US$600 million per medicine. That is a modeled scenario, not a measured result from the installed computer.
A Quantum System in Business Infrastructure
The installation matters as a test of whether a quantum computer can be housed in a commercial data center alongside the infrastructure organizations already use, rather than only in a dedicated research setting. If the design can scale as Diraq expects, it could make it easier for data center operators and customers to assess how quantum systems might connect to conventional computing. The current deployment, however, establishes a site and operating system—not broad customer access, useful business applications or a proven cost advantage.
Diraq’s compact-footprint and power figures speak to a practical constraint in quantum development: specialized systems may need space, cooling, wiring and other support infrastructure. The company argues its silicon spin approach can limit those demands. Its comparisons and forecasts are company claims, and the eight-qubit system does not yet establish how those requirements will change at larger scale.
The accompanying medicine analysis may attract attention because drug development is costly and slow. But the proposed savings depend on improving clinical trial outcomes and identifying failed candidates earlier. No clinical or economic benefit has been shown from this deployment; the report’s estimates describe a possible future application of more capable quantum computers.
Products Worth Considering
Apple MacBook Air 13-inch Laptop with M5 Chip, 16GB Memory, 512GB SSD, 12MP Center Stage Camera, and Wi-Fi 7, Sky Blue
Samsung 27-inch Odyssey OLED G6 QD-OLED QHD Gaming Monitor (G61SH)
EcoFlow DELTA 3 Portable Power Station, 1024Wh, 1800W
As an affiliate, we earn on qualifying purchases.
From Quantum Research to Data Centers
Diraq’s announcement presents the Sydney installation as a step from laboratory development toward deployment in ordinary computing facilities. Its stated approach uses silicon spin qubits and semiconductor manufacturing methods. The company’s proposition is that this could allow processors to scale while making fewer changes to the surrounding facility than some other quantum designs may require. The announcement does not provide independent comparisons of system performance, operating costs or scalability.
The company also points to recent funding and program developments. It says it advanced to Stage C of DARPA’s Quantum Benchmarking Initiative, which evaluates routes to utility-scale quantum computing, and that it signed a US$38 million letter of intent with the US Department of Commerce under the CHIPS and Science Act. These developments provide context for Diraq’s effort, but they do not establish that the deployed system has reached utility-scale capability.
In the report, Diraq cites analysis based on a 2010 industry cost study published in Nature Reviews Drug Discovery and FDA approval data. It estimates that a 10-percentage-point rise in clinical trial success rates could correspond to around 50% more potential medicines reaching patients each year—up to 25 additional medicines in a US-sized market. These figures are scenario estimates and are not outcomes observed at Equinix.
“We are now at a point where quantum computing can start to reach industries and the people they serve.”
— Andrew Dzurak, Diraq CEO and founder
Scale, Performance and Access Still Unclear
The announcement does not detail what workloads the eight-qubit computer has completed, provide benchmark results, or say whether external customers can access it. It is also unclear what level of availability, reliability or operating performance the system has demonstrated in the data center. Diraq’s description of the deployment as the first of its kind is attributed to the company; the supplied material does not include independent verification.
The proposed expansion to up to 256 qubits within a year remains a target. The company has not established in this announcement whether it will meet that schedule, what performance the larger system would achieve, or how its power and footprint would compare with the present installation. The medicine savings estimates likewise depend on future capabilities and assumptions, and should not be read as demonstrated health or financial outcomes.
Diraq’s Planned System Upgrade
The next stated milestone is Diraq’s planned upgrade of the Sydney system to as many as 256 qubits within a year. Further reporting will be needed to establish whether the company reaches that target and to assess any published benchmarks, customer access, or applications run on the machine. Diraq’s Quantum at Work report sets out potential use cases, but the company has not announced that the installed system is being used to deliver the modeled medicine-development benefits.
For now, the clearest measure of progress will be evidence about the system’s operation and scaling—not projections alone. Details on performance, reliability, integration requirements and independent evaluation would help show whether this data center installation can support practical quantum computing at a larger scale.
Key Questions
Where is Diraq’s quantum computer installed?
Diraq says its eight-qubit system is operating at Equinix’s data center in Sydney, Australia.
How large and power-intensive is the current system?
Diraq reports that the current installation occupies about 170 square feet and draws less than 20 kilowatts. These are company-provided figures.
Has Diraq already upgraded the computer to 256 qubits?
No. The system currently operates with eight qubits. Diraq says it is targeting an upgrade to as many as 256 qubits within a year.
Does the installation show that quantum computing can save money on drug development?
No such savings have been demonstrated by this installation. Diraq’s report models that a 10-percentage-point increase in clinical trial success rates could save about US$600 million per medicine; this is a projected scenario, not a measured outcome.
Source: thequantuminsider.com
